170 related articles for article (PubMed ID: 22009326)
21. Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.
Therkildsen C; Jönsson G; Dominguez-Valentin M; Nissen A; Rambech E; Halvarsson B; Bernstein I; Borg K; Nilbert M
Eur J Cancer; 2013 Apr; 49(6):1226-35. PubMed ID: 23245329
[TBL] [Abstract][Full Text] [Related]
22. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas.
Yoon JH; Song JH; Zhang C; Jin M; Kang YH; Nam SW; Lee JY; Park WS
J Pathol; 2011 Apr; 223(5):618-25. PubMed ID: 21341273
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.
Ptashkin RN; Pagan C; Yaeger R; Middha S; Shia J; O'Rourke KP; Berger MF; Wang L; Cimera R; Wang J; Klimstra DS; Saltz L; Ladanyi M; Zehir A; Hechtman JF
Mol Cancer Res; 2017 Jun; 15(6):708-713. PubMed ID: 28184012
[TBL] [Abstract][Full Text] [Related]
25. Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas.
Jones AM; Thirlwell C; Howarth KM; Graham T; Chambers W; Segditsas S; Page KM; Phillips RK; Thomas HJ; Sieber OM; Sawyer EJ; Tomlinson IP
J Pathol; 2007 Nov; 213(3):249-56. PubMed ID: 17893889
[TBL] [Abstract][Full Text] [Related]
26. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
[TBL] [Abstract][Full Text] [Related]
27. Over-expression of AURKA, SKA3 and DSN1 contributes to colorectal adenoma to carcinoma progression.
Chuang TP; Wang JY; Jao SW; Wu CC; Chen JH; Hsiao KH; Lin CY; Chen SH; Su SY; Chen YJ; Chen YT; Wu DC; Li LH
Oncotarget; 2016 Jul; 7(29):45803-45818. PubMed ID: 27329586
[TBL] [Abstract][Full Text] [Related]
28. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
[TBL] [Abstract][Full Text] [Related]
29. Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression.
Uchiyama T; Takahashi H; Endo H; Sugiyama M; Sakai E; Hosono K; Nagashima Y; Inayama Y; Wada K; Hippo Y; Nakajima A
Int J Oncol; 2011 Oct; 39(4):935-40. PubMed ID: 21720710
[TBL] [Abstract][Full Text] [Related]
30. The candidate oncogene ZNF217 is frequently amplified in colon cancer.
Rooney PH; Boonsong A; McFadyen MC; McLeod HL; Cassidy J; Curran S; Murray GI
J Pathol; 2004 Nov; 204(3):282-8. PubMed ID: 15476264
[TBL] [Abstract][Full Text] [Related]
31. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis.
Hidaka S; Yasutake T; Takeshita H; Kondo M; Tsuji T; Nanashima A; Sawai T; Yamaguchi H; Nakagoe T; Ayabe H; Tagawa Y
Clin Cancer Res; 2000 Jul; 6(7):2712-7. PubMed ID: 10914715
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
33. BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity.
Clemo NK; Collard TJ; Southern SL; Edwards KD; Moorghen M; Packham G; Hague A; Paraskeva C; Williams AC
Carcinogenesis; 2008 Apr; 29(4):849-57. PubMed ID: 18204076
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling of laterally spreading tumors.
Minemura S; Tanaka T; Arai M; Okimoto K; Oyamada A; Saito K; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Kishimoto T; Yokosuka O
BMC Gastroenterol; 2015 Jun; 15():64. PubMed ID: 26048755
[TBL] [Abstract][Full Text] [Related]
35. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
36. Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas.
Zarzour P; Boelen L; Luciani F; Beck D; Sakthianandeswaren A; Mouradov D; Sieber OM; Hawkins NJ; Hesson LB; Ward RL; Wong JW
Genes Chromosomes Cancer; 2015 May; 54(5):303-14. PubMed ID: 25726927
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
38. Expression of growth factors and their receptors in human early colorectal carcinomas: immunohistochemical study.
Shirai H; Ueno E; Osaki M; Tatebe S; Ito H; Kaibara N
Anticancer Res; 1995; 15(6B):2889-94. PubMed ID: 8669884
[TBL] [Abstract][Full Text] [Related]
39. Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Vonen B; Florholmen J
Cancer Immunol Immunother; 2009 Nov; 58(11):1897-905. PubMed ID: 19350238
[TBL] [Abstract][Full Text] [Related]
40. NF-kappaB and apoptosis in colorectal tumourigenesis.
Aranha MM; Borralho PM; Ravasco P; Moreira da Silva IB; Correia L; Fernandes A; Camilo ME; Rodrigues CM
Eur J Clin Invest; 2007 May; 37(5):416-24. PubMed ID: 17461988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
